Noninfectious Uveitis Clinical Trial
Official title:
A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Noninfectious Uveitis
The primary objective of this study is to evaluate the efficacy of filgotinib versus placebo for the treatment of the signs and symptoms of noninfectious uveitis as measured by the percentage of participants failing treatment for active noninfectious uveitis by Week 24.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01789320 -
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
|
Phase 1/Phase 2 | |
Completed |
NCT01243983 -
Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis
|
Phase 3 |